Trial Profile
The trial to set a suitable period of using esomeprazole and polaprezinc to cure the gastric ulcer after endoscopic submucosal resection (ESD) for mucosal cancers of the stomach.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Polaprezinc (Primary)
- Indications Gastric ulcer
- Focus Therapeutic Use
- 28 Jun 2013 New trial record